Title: Bernard Barlaam, et al. Abstract 1650: Discovery of AZD4573, a potent and selective inhibitor of CDK9 that enables transient target engagement for the treatment of hematologic malignancies. Cancer Research. July 2018. 78(13): Supplement.
1427325-88-9 | 1-(1-pentyl-1H-indol-3-yl)-2-(m-tolyl)ethanone | AA01EOUL
1185282-19-2 | N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-[(3-fluorophenyl)methyl]-1H-indazole-3-carboxamide | AA01EP3M
13616-29-0 | 4,4'-(Carbonylbis(azanediyl))bis(N-(4-methylpyrimidin-2-yl)benzenesulfonamide) | AA01EPD6 | MFCD11114386
62600-81-1 | (1R)-1-[[(1-oxohexadecyl)oxy]methyl]-2-(phosphonooxy)-9Z-octadecenoicacidethylester | AA01EPJH
1465-22-1 | N-(3-methylphenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-propanamide,monohydrochloride | AA01EPPH
93138-53-5 | 2-methyl-1-(phenylmethyl)-piperazine,dihydrochloride | AA01EPW6 | MFCD02671087
1082721-49-0 | N-[1-[2-(3-methylphenyl)ethyl]-4-piperidinyl]-N-phenyl-propanamide,monohydrochloride | AA01EQ5Q
949588-40-3 | ORG25935-SCH900435 | AA01EQC2 | MFCD19708017
1156737-05-1 | 1-[4-(4-Fluorophenoxy)phenyl]ethan-1-ol | AA01EQQ1 | MFCD12422601
1280655-40-4 | (3S)-3-Amino-4,4,4-trifluoro-1-phenylbutan-1-one | AA01ERK1 | MFCD28002556
